Nature Reviews Clinical Oncology
(ISSN: 1759-4774, 1759-4782)
Formerly Nature Clinical Practice Oncology
Show only:
Journal CME
2009 - 6 (10)
- Molecular imaging of solid tumors: exploiting the potential.
- Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer.
- Src kinases as therapeutic targets for cancer.
- Radiotherapy: IMRT reduces xerostomia and potentially improves QoL.
- Hematology: Thalidomide maintenance in multiple myeloma.
- Chemotherapy: Adjuvant chemotherapy in older patients with breast cancer.
- Chemotherapy: Irinotecan or etoposide as front-line therapy for SCLC?
- Chemotherapy: Optimizing irinotecan regimens for colorectal cancer.
- Chemotherapy: Topotecan or treosulfan--that is the question.
- The Holy Grail of biomarkers.
- An overview of small-molecule inhibitors of VEGFR signaling.
- Neurological adverse effects caused by cytotoxic and targeted therapies.
- Role of cancer stem cells in pancreatic ductal adenocarcinoma.
